S. Tiberi (London, United Kingdom), R. Duarte (Porto, Portugal)
Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients
V. Raj R. (Puducherry, India), T. Anitha (Puducherry, India), R. Pajanivel (Puducherry, India), C. Adithan (Puducherry, India), K. Surendra Menon (Puducherry, India)
|    |
Isoniazid mono-resistance negatively affects tuberculosis treatment outcomes in Europe
B. Karo (Berlin, Germany), A. Kohlenberg (Stockholm, Sweden), V. Hollo (Stockholm, Sweden), R. Duarte (Porto, Portugal), L. Fiebig (Morogoro, Tanzania), S. Jackson (Dublin, Ireland), C. Kearns (Belfast, United Kingdom), C. KöDmöN (Stockholm, Sweden), M. Korzeniewska-Kosela (Warsaw, Poland), D. Papaventsis (Athens, Greece), I. Solovic (Vysne Hagy, Slovakia), D. Van Soolingen (Bilthoven, Netherlands), M. van der Werf (Stockholm, Sweden)
| |
World Health Organization guidance on the treatment of isoniazid-resistant tuberculosis
L. Gonzalez Angulo (Geneva, Switzerland), D. Falzon (Geneva, Switzerland), E. Jaramillo (Geneva, Switzerland), K. Weyer (Geneva, Switzerland)
| |
Management of tuberculosis in the European Union: a multicentre audit
S. Rosales-Klintz (Stockholm, Sweden), L. D’Ambrosio (Tradate, Italy), R. Centis (Tradate, Italy), R. Verduin (Oegstgeest, Netherlands), M. Amicosante (Rome, Italy), A. Correia (Porto, Portugal), A. Cirule (Riga, Latvia), R. Duarte (Porto, Portugal), B. Gadzheva (Sofia, Bulgaria), G. Gualano (Rome, Italy), H. Kunst (London, United Kingdom), F. Palmieri (Rome, Italy), V. Riekstina (Riga, Latvia), D. Stefanova (Sofia, Bulgaria), S. Tiberi (London, United Kingdom), G. Sotgiu (Sassari, Italy), G. Migliori (Tradate, Italy), M. Van Der Werf (Stockholm, Sweden)
| |
Clinical significance of low serum isoniazid level among the patients with drug-sensitive pulmonary tuberculosis who showed delayed smear or culture conversion.
J. Kim (Incheon, Republic of Korea), Y. Kim (Bucheon, Republic of Korea), J. Kim (Uijeongbu, Republic of Korea), J. Hah (Incheon, Republic of Korea), A. Shin (Incheon, Republic of Korea), H. Kim (Incheon, Republic of Korea), J. Ahn (Incheon, Republic of Korea)
| |
Protective capacity of a new TB vaccine
V. Gergert (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)
| |
Short 12-month regimen with intravenouse linezolid for MDR-TB: treatment outcomes and first follow up results.
N. Lytvynenko (Kyiv, Ukraine), H. Varytska (Kyiv, Ukraine), M. Pogrebna (Kyiv, Ukraine), Y. Senko (Kyiv, Ukraine), O. Chobotar (Kyiv, Ukraine)
| |
Regulation of apoptosis via the PARK7 interactome in peripheral blood mononuclear cells donated by tuberculosis patients vs. controls and the response to treatment: a systems biology approach.
G. Vavougios (Larisa, Greece), S. Zarogiannis (Larisa, Greece), K. Krogfelt (Copenhagen, Denmark), K. Gourgoulianis (Larisa, Greece)
| |